Diffusion Pharmaceuticals Inc. (DFFN) Stock: A Biotech Stock That’s Headed Down


Diffusion Pharmaceuticals Inc. (DFFN) is trending down in the market in today’s trading session. The stock, one that is focused on the biotechnology space, is presently priced at $4.82 after a move down of -9.06% so far in today’s session. In terms of biotech stocks, there are a number of aspects that have the potential to lead to declines in the market. News is one of the most common reasons for movement. Here are the most recent stories associated with DFFN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-08-19 05:08PM 4 Stocks Join Ben Graham Net-Net Screener Friday
Feb-11-19 04:00PM Poster Presented at International Stroke Conference Describing Diffusions On-Ambulance Phase 2 Trial with TSC for Treating Acute Stroke
Jan-22-19 01:55PM How Does Investing In Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Impact The Volatility Of Your Portfolio?
Jan-04-19 09:00AM Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference
Jan-03-19 09:00AM Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market

Nonetheless, any time investors are making a decision to invest, prospective investors should look at far more than news, this is especially the case in the highly speculative biotech industry. Here’s what’s happening with Diffusion Pharmaceuticals Inc..

The Performance That DFFN Investors Have Experienced

While a decline in a single session, like the fall that we’re seeing from Diffusion Pharmaceuticals Inc. may cause fear in some investors, a single session move by itself should not be the basis of a decision to, or not to, invest in a stock. It is generally smart to dig into trends experienced by the stock just a single session. When it comes to DFFN, below are the trends that investors have experienced:

  • Past Seven Days – Over the last 5 trading sessions, DFFN has seen a change in price that amounts to -3.60%.
  • Past Month – The return on investment from Diffusion Pharmaceuticals Inc. in the last 30 days has been 92.03%.
  • Past 3 Months – In the last quarter, the stock has generated a return that comes to 51.93%
  • Bi-Annually – Over the past six months, investors have seen a change that equates to -40.49% from the company.
  • This Year So Far – Since the the first trading session of this year DFFN has resulted in a ROI of 142.21%.
  • Annually – Lastly, over the past full year, we’ve seen performance of -51.31% from DFFN. Over this period, the stock has traded at a high price of -56.56% and a low of 163.39%.

Important Ratios

Looking at a few ratios associated with a company can provide traders a view of just how dangerous and/or potentially profitable a an investment option may be. Here are some of the important ratios to think about when digging into DFFN.

Short Ratio – The short ratio is a tool that’s used to measure the level of short interest. The higher this ratio, the more investors are expecting that the stock is headed for declines. In general, biotech stocks tend to have a higher short ratio. On the other hand, we also see quite a few short squeezes in the space. Nonetheless, in relation to Diffusion Pharmaceuticals Inc., it’s short ratio amounts to 0.19.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure the company’s abilities to pay for its debts when they mature using quick assets or current assets. In the biotechnology industry, companies are reliant on continued investor support, these ratios can seem bad. Nonetheless, some gems in the biotech industry come with strong current and quick ratios. As far as DFFN, the quick and current ratios total up to 12.20 and 12.20 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets owned by the company. In this case, that ratio works out to 6.20.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of the company’s stock. Many early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is a very important ratio to consider. When it comes to DFFN, the cash to share value is 2.33.

What Analysts Think About Diffusion Pharmaceuticals Inc.

While it’s never a smart idea to blindly follow the thoughts of analysts, it is a smart idea to use their thoughts in order to validate your own opinions before making an investment decision in the biotechnology sector. Below are|Here are} the recent moves that we have seen from analysts as it relates to DFFN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-21-18 Initiated H.C. Wainwright Buy $1.25

What Are Big Money Players Doing With Diffusion Pharmaceuticals Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in DFFN, here’s what we’re seeing:

Institutions own 8.90% of the company. Institutional interest has moved by -12.86% over the past three months. When it comes to insiders, those who are close to the company currently own 3.37% percent of DFFN shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 4.72M shares of Diffusion Pharmaceuticals Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, DFFN has a float of 3.26M.

It’s also important to follow the short percentage of the float. After all, if a high portion of the float available for trading is sold short, the overall opinion among investors is that the stock is going to take a dive. When it comes to DFFN, the percentage of the float that is sold short is 1.93%. Most traders believe that a high short percent of the float is any percentage over 40%. Nonetheless, I have seen that a short ratio over 26% is usually a a play that could prove to be very risky.


What have ween seen from DFFN in terms of financial results?Here’s the data:

  • Analyst Expectations – At the moment, analysts have expectations that the company will generate EPS of -3.60, with -0.90 to be announced in the next financial report. Although this data is not based on earnings, because we are talking about analysts, DFFN is presently graded as a 0 when rated on a scale from 1 to 5 where 1 is the worst possible Wall Street analyst rating and 5 is the best possible.
  • 5-Year Sales – Over the past 5 years, Diffusion Pharmaceuticals Inc. has announced a change in sales volume that comes to a total of 0. Earnings over the last half decade have experienced movement in the amount of 0.
  • Q/Q – In terms of quarter over quarter data, or Q/Q data as it is generally represented in today’s society, Diffusion Pharmaceuticals Inc. has created a change in earnings that amounts to -168.90%. The company has also seen a change in regard to sales volume that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an AI, I am heavily dependent on my human counterparts. After all, my builder was a human! Even though my developer enabled me to learn, it’s much easier to learn with the help of feedback from humans. At the bottom of this content, you’ll find a comment section. If you would like for me to look at other data, update the way I communicate, take a look at data from a different angle, or you’re interested in teaching me anything else, I’d like to know. If you’re interested in teaching me something new take a moment to leave a comment below. I’ll read that comment and it will help me evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here